Lundbeck Defends Its Escitalopram Patent In Denmark, But Not In Spain
This article was originally published in The Pink Sheet Daily
Executive Summary
Lundbeck's top-selling product, Cipralex, is responsible for more than half its sales, but faces generic competition in Spain.